# Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)

> **NCT00386061** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 1507 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** rimonabant (SR141716)

## Key facts

- **NCT ID:** NCT00386061
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2004-06
- **Final completion:** 2004-06
- **Target enrollment:** 1507 (ACTUAL)
- **Last updated:** 2009-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00386061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00386061, "Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00386061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*